DE3889938D1 - Injizierbare Lösungen von Gamma-Globulin. - Google Patents

Injizierbare Lösungen von Gamma-Globulin.

Info

Publication number
DE3889938D1
DE3889938D1 DE3889938T DE3889938T DE3889938D1 DE 3889938 D1 DE3889938 D1 DE 3889938D1 DE 3889938 T DE3889938 T DE 3889938T DE 3889938 T DE3889938 T DE 3889938T DE 3889938 D1 DE3889938 D1 DE 3889938D1
Authority
DE
Germany
Prior art keywords
injectable solutions
gamma globulin
globulin
gamma
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3889938T
Other languages
English (en)
Other versions
DE3889938T2 (de
Inventor
Yutaka Hirao
Kazuo Takechi
Katuhiro Uriyu
Yahiro Uemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of DE3889938D1 publication Critical patent/DE3889938D1/de
Application granted granted Critical
Publication of DE3889938T2 publication Critical patent/DE3889938T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE3889938T 1987-02-06 1988-02-05 Injizierbare Lösungen von Gamma-Globulin. Expired - Lifetime DE3889938T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62027031A JP2547556B2 (ja) 1987-02-06 1987-02-06 ｒ−グロブリンの液状製剤

Publications (2)

Publication Number Publication Date
DE3889938D1 true DE3889938D1 (de) 1994-07-14
DE3889938T2 DE3889938T2 (de) 1994-11-03

Family

ID=12209701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3889938T Expired - Lifetime DE3889938T2 (de) 1987-02-06 1988-02-05 Injizierbare Lösungen von Gamma-Globulin.

Country Status (7)

Country Link
US (1) US4876088A (de)
EP (1) EP0278422B1 (de)
JP (1) JP2547556B2 (de)
KR (1) KR960008653B1 (de)
CA (1) CA1331135C (de)
DE (1) DE3889938T2 (de)
ES (1) ES2052615T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
JPH07238036A (ja) * 1994-02-28 1995-09-12 Green Cross Corp:The 静注用グロブリン液状組成物のグロブリン二量体増加抑制方法
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
US6124437A (en) * 1997-03-19 2000-09-26 Welfide Corporation Immunoglobulin preparation and preparation process thereof
EP0973549A2 (de) * 1997-04-07 2000-01-26 Cangene Corporation Intravenöse immunglobulinzusammensetzungen die ein nichtionisches oberfläche-aktives agens enthält mit verbesserten pharmakokinetischen eigenschaften
CN1149100C (zh) † 1997-10-23 2004-05-12 三菱制药株式会社 可室温贮存的免疫球蛋白静脉注射制剂
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1475101B1 (de) 2002-02-14 2010-10-27 Chugai Seiyaku Kabushiki Kaisha Antikörper enthaltende pharmazeutische lösungen
JP2005320248A (ja) * 2002-04-22 2005-11-17 Mitsubishi Pharma Corp 免疫グロブリン製剤の製造方法
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US20050136055A1 (en) * 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20070184050A1 (en) * 2003-12-25 2007-08-09 Kirin Beer Kabushiki Kaisha Stable water-based medicinal preparation containing antibody
KR20080031684A (ko) 2005-06-14 2008-04-10 암젠 인코포레이티드 자가 - 완충성 단백질 제형
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
AR078161A1 (es) * 2009-09-11 2011-10-19 Hoffmann La Roche Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
JP5734985B2 (ja) 2009-09-17 2015-06-17 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法
ES2381828B1 (es) 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
BR112019007858A2 (pt) 2016-10-21 2019-07-02 Amgen Inc formulações farmacêuticas e métodos para produzir as mesmas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840532B2 (ja) * 1975-04-08 1983-09-06 カブシキガイシヤ ミドリジユウジ Ｉｇａ オヨビ ｉｇｍ ノネツアンテイカホウ
JPS553721A (en) * 1978-06-21 1980-01-11 Morinaga Milk Ind Co Ltd Production of powder of colostrum
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
EP0035204B2 (de) * 1980-03-05 1991-05-22 Miles Inc. Pasteurisierte therapeutisch aktive Proteinzusammensetzungen
JPS56127320A (en) * 1980-03-10 1981-10-06 Mochida Pharmaceut Co Ltd Gamma-globulin pharmaceutical
US4477432A (en) * 1981-05-01 1984-10-16 Cutter Laboratories, Inc. Oral immune globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4412990A (en) * 1982-07-02 1983-11-01 Cutter Laboratories, Inc. Composition having enhanced opsonic activity
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH07103045B2 (ja) * 1986-07-09 1995-11-08 株式会社ミドリ十字 非化学修飾γ−グロブリンの加熱処理方法
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin

Also Published As

Publication number Publication date
CA1331135C (en) 1994-08-02
EP0278422A2 (de) 1988-08-17
JPS63192724A (ja) 1988-08-10
KR880009635A (ko) 1988-10-04
ES2052615T3 (es) 1994-07-16
EP0278422A3 (en) 1990-04-04
DE3889938T2 (de) 1994-11-03
JP2547556B2 (ja) 1996-10-23
US4876088A (en) 1989-10-24
KR960008653B1 (ko) 1996-06-28
EP0278422B1 (de) 1994-06-08

Similar Documents

Publication Publication Date Title
DE3889938D1 (de) Injizierbare Lösungen von Gamma-Globulin.
FI880985A (fi) Framstaellning av mycket rent syre.
DE3870004D1 (de) Garantieverschluss.
DE3850598D1 (de) Substituierte Di-t-butylphenole.
FI880591A0 (fi) Cykliska dioner.
IT8821018A0 (it) Proietto.
IT8322666A0 (it) Concentrato di gamma globulina stabilizzato.
DE3861029D1 (de) Handpeilkompass.
IT8121831A0 (it) Chiusura di attivazione per fiala.
FI882069A0 (fi) Transportanordning foer burkaemnen i en burksvetsmaskin.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
FI891129A (fi) Foerfarande foer framstaellning av buten-i.
FI833408A (fi) Troeskningsfoerfarande samt anordning foer dess tillaempning.
FI843034A (fi) Plasmabraennare samt foerfarande foer dess anvaendning.
FI842469A (fi) Lockkonstruktion samt foerfarande foer dess framstaellning.
ES2021844B3 (es) Pantalla antideslumbramiento.
FI890925A0 (fi) Drivanordning foer ett arbetselement vid en industrimaskin.
NO883386D0 (no) Laaseanordning til containere.
DE3381749D1 (de) Impulskorrigierer.
FI841568A0 (fi) Injektionsspruta, saerskilt injektionsspruta foer engaongsbruk.
DE3881393D1 (de) Dehydrobromierung von substituiertem alpha-halocumol.
NO884360D0 (no) Substituerte 2-metylisoksazolidiner.
ATE48296T1 (de) Faekalienrueckstauverschluss.
NO910670L (no) Cyklisk substituerte ketoestere.
ES1003767Y (es) Tentetieso.

Legal Events

Date Code Title Description
V448 Application of spc

Free format text: PRODUCT NAME: IMMUNOGLOBULIN VOM MENSCHEN; REGISTRATION NO/DATE: 526A/91, 19921130

Spc suppl protection certif: 194 75 022

Filing date: 19941208

8364 No opposition during term of opposition
V454 Spc application withdrawn or to be regarded as withdrawn

Free format text: PRODUCT NAME: IMMUNOGLOBULIN VOM MENSCHEN; REGISTRATION NO/DATE: 526A/91, 19921130

Spc suppl protection certif: 194 75 022

Filing date: 19941208

8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP